Bell Potter has defeated a lawsuit by Nicholas Bolton’s Keybridge Capital over a 2015 phone call which lasted one minute and 18 seconds in which the investment firm was accused of committing its client to buy $10 million worth of shares in defunct Molopo Energy.
A judge who lashed “unsatisfactory cooperation” between Chubb and British automotive distributor Inchcape has found the insurer’s policy covers some but not all costs stemming from a cyber attack which allegedly caused over $4 million in loss.
The lead auditor for Big Un’s flawed 2017 independent audit, which overstated the failed video company’s cash and cash equivalents by $8.2 million, has been convicted of failing to comply with auditing standards following an investigation by ASIC.
The NSW Independent Commission has found that pork barrelling, in which a minister directs public funds for partisan political purposes, could sometimes amount to criminal corruption and has called for better regulation of grants funding.
Salaries for junior to mid-level lawyers have increased by 20 per cent in the last year but the legal market is facing difficulties as firms struggle to fill positions, causing the traditional law firm pyramid structure to “collapse”, a report has found.
The corporate regulator will challenge a bid by payday lenders Cigno and BHF to stay its case pending their appeal to the High Court.
Irish insurer Zurich Insurance has refused consent for a class action over a defective New Zealand apartment block to proceed in the NSW Supreme Court as it mulls a High Court challenge to the case.
The CFMMEU and two of its officials have been hit with the maximum penalty for allegedly breaching right of entry rules and calling a safety advisor “disgusting homophobic slurs” at a worksite on the $5.4 billion Queensland Cross River Rail project.
Bristol-Myers Squibb unit Celgene and two generic drug makers have withdrawn an application for ACCC approval of a patent settlement that would have allowed for an early launch of a generic version of blockbuster cancer drug Revlimid.
A former Greenwoods & Freehills partner will argue he is entitled to whistleblower protection in his lawsuit against the tax advisory firm and Lendlease, alleging he was forced to leave after refusing to put his name to a tax return and making protected disclosures.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
